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Abstract Digital healthcare information systems promise to 
improve care efficiency, to reduce complexity for patients, and 
to increase access to information and advance research efforts. 
A prominent example are multi-sided-platforms (MSP), which 
are essentially an information business, linking key healthcare 
stakeholders for individualized as well as aggregated information 
services. However, platform-based health innovation relies on 
the extensive collection, storage, and use of sensitive health 
information, raising issues of information privacy. This study 
uses the privacy calculus perspective to shed light on patients’ 
trade-off considerations. We use the case of a MSP, which 
connects patients, care providers and researchers, in order to 
model a multi-level calculus for health information of terminally 
ill patients. These insights inform stepwise consent options, 
which highlight the trade-offs between information value and 
patient privacy. By reflecting on the implications for patient 
empowerment this conceptual paper develops a research agenda 
on how to study and design responsible health information 
systems. 
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1 Introduction 
 
The delivery of healthcare and disease management are information intensive fields, 
in which the effective exchange of sensitive information is a crucial success factor. 
Digital technologies have started to transform healthcare worldwide based on 
promises of decreased costs and improved quality. Digital multi-sided platforms 
(MSP) act as intermediaries between different stakeholders such as patients, 
providers and purveyors (Davidson et al., 2018; Hagiu and Wright, 2015). Especially 
in light of severe neurological diseases like amyotrophic lateral sclerosis (ALS), 
healthcare providers struggle to keep up with the pace of the progressing symptoms 
and patients’ increasing need for care, therapeutic interventions, assistive 
technologies, and medication (Funke et al., 2015). Here, MSP create new possibilities 
to promote a patient-centric model of care delivery and at the same time cut costs 
(Kuziemsky and Vimarlund, 2018). Several studies suggest that the use of 
information systems can enhance patient empowerment (Risling et al., 2017, Angst 
and Agarwal 2004, Deng et al., 2013). 
 
However, there is a promise-delivery gap concerning technology and data driven 
improvement of healthcare. In order to close the gap, challenges and wider 
implications for all stakeholders need to be considered (Davidson et al., 2018). 
Platform-based healthcare innovation claims are premised on the centralization, 
access and efficient use of large amounts of sensitive information. Thus, information 
privacy is becoming a critical topic involving perplexing trade-offs for patients: They 
have to weigh promises of sharing information against the potential risks and 
concerns related to losing control over their information (Laufer and Wolfe, 1977; 
Culnan and Armstrong, 1999). The sharing of medical information is not limited to 
impacting individuals only but yields promises to advance public health research 
efforts of profound societal relevance. In the context of ALS, data driven care 
studies appear to be particularly promising as the disease is rare (about 1% of the 
population are affected) and without any known cure. In addition to progressing the 
body of medical knowledge, direct impact of research efforts for the patient 
community can be expected. Ethical discourses evolve around data donations and 
the question whether medical data should be considered a common good (Hummel 
et al., 2019).  
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While benefits of using large amounts of medical data to foster innovation, increase 
efficiencies or improve medical and care research become apparent, they must be 
balanced with protecting personal privacy. The issue of information exchange on a 
healthcare platform has rarely been examined from a patient perspective and with 
respect to patient sovereignty and empowerment (Shen et al., 2019). The purpose of 
this research is thus to use the privacy calculus perspective in order to illustrate the 
dilemmas of terminally ill patients in the context of a healthcare MSP. More 
specifically it will address the question: (How) is it possible to balance information needs and 
patient privacy, while ensuring patients’ empowerment? 
 
This research will examine multiple trade-offs that arise from patients’ perspectives 
on numerous information purposes from a privacy calculus perspective. Our 
empirical setting is Ambulanzpartner Soziotech GmbH (APST), a MSP that 
orchestrates case management for severe neurological diseases. APST acts as an 
intermediary between patients and care providers, and thus as information 
aggregator, guardian and gatekeeper (Fürstenau et al. 2019). It also collects and uses 
information for research purposes. Based on a rich case description we first shed 
light on the particularities of the healthcare MSP and its information centric 
practices. Focusing on the patient’s perspective, privacy calculus theory is used as 
lens on the value of personal health information. We have used an extreme case 
sampling strategy to select the case, expecting that it will yield more clearly articulated 
views on privacy trade-offs. We propose exemplary design options that have the 
potential to enhance patients’ information sovereignty and meet information needs 
appropriately. Finally, we will discuss relevant implications and provide an outlook 
for empirical investigations. 
 
Our contributions are twofold: First, we contribute to the information privacy 
literature by enhancing the understanding of terminally ill patients’ privacy 
perceptions in a digital healthcare context. We explore possible contingency factors 
that extend the privacy calculus in this realm. Second, we inform the design of a 
stepwise consent option that paves the way for an informed calculus. We further 
discuss and reflect on implications of platform-based information exchange in 
healthcare for patient empowerment to enable responsible healthcare innovation. 
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2 Case Background 
 
We use an extreme case to examine data-based healthcare management1. The 
operating logic of APST and the nature of information exchange via the healthcare 
MSP provide a backdrop for a deeper understanding of the trade-offs that patients 
face. 
 
2.1 Platform-based Innovation for ALS Care 
 
ALS is considered a “relentlessly progressive and fatal neurodegenerative disease 
characterized by progressive weakness of voluntary muscles of movement as well as 
those for swallowing, speech and respiration” (Soriani and Desnuelle 2017, p. 288). 
Due to the severity and swift progression of the symptoms, patients are not only 
overwhelmed by the dire prognosis of a non-curable disease, but face challenges of 
organizing and adjusting medical care and assistive technology as the disease 
progresses. Thus, ALS care has profound ethical issues during treatment and care 
(for a review, see Seitzer et al. 2016). One of the several shortcomings in the German 
ALS Care System is the significant delay of providing assistive technology due to 
long insurance approval processes (Funke et al., 2015). APST aims to address these 
gaps and provides an illustration of how a digital health platform can facilitate the 
coordination and inter-professional cooperation of multiple providers as a multi-
sided transaction platform model. APST is operating under two different logics: 
providing care management on the one hand and functioning as research 
infrastructure on the other. By maintaining the electronic health record and 
connecting patients and doctors with care providers and assistive technology 
providers, the platform aims to transform the field to a new way of care 
orchestration. Opportunities are created that lead not only to complexity reduction 
for individual patients but also promise an increase in efficiency and effectiveness of 
care provision (Fürstenau et al., 2018). Patient feedback on care services and devices 
is solicited in order to improve the quality of care and faciltiate a learning cycle. At 
the same time, the platform is connecting the patient pool with research partners to 
conduct medical and care studies or improve platform efficiency. Thus, the 
disclosure of personal health information holds not only potential benefits for the 
                                                     
1 Based on purposeful sampling and extreme case selection (Yin, 2009) we investigate a rare and terminal disease. 
The distinctive setting of a disease with no known cure functions as a magnifying glass to patient’s perceptions and 
reveals specificities of risk and benefit perceptions that emerge and manifest themselves in a more pronounced way 
in this context.  
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orchestration of patients’ care but also for the platform and the related partners 
(service providers and researchers). 
 
2.2 Information as Main Resource  
 
Innovative modes of interaction are possible because of patient’s health and medical 
information: As a digital intermediary, which collects, stores and redistributes 
information, APST relies on the extensive use and economization of patient data. 
APST thus combines the data-economy logic of information accumulation with the 
goal of providing a patient-centric care model. This raises potential conflicts of 
interest as it takes practices critically discussed in the context of data capitalism 
(Zuboff, 2019) to the realm of care. For APST, patient information is one of the 
main resources. Drawing on Levitan (1982), we depicted the information lifecycle 
for APST in Figure 1. 
 
 
 
Figure 1: APST Information Resource Lifecycle 
(adapted from Levitan, 1982, p. 48) 
 
 
Information is acquired and generated by patients who provide personal information 
or a health record to the platform, give feedback or respond to surveys and take part 
in trials. By storing it centrally, APST is able to transform and prepare the 
information for further purposes. The different modes of interaction and the 
different stakeholders that are involved are illustrated by the flow of information via 
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information products to the various users. The information lifecycle sheds light on 
the dynamics that arise with information as the main resource from the perspective 
of APST and illustrates the diverse purposes and types of use for collected 
information. Patient information, which is provided by consenting patients, is 
essential for a successful operation of the platform. Empowering patients to make 
informed choices about providing information is crucial in order to ensure that 
APST is not only extracting value from the information but also – and primarily - 
creating value that will benefit patients. It is therefore crucial to understand how 
patients reach the decisions to consent and to share. We take the patients’ 
perspective and model trade-offs initially within the parameters of the case before 
discussing options of generalizability. 
 
3 Health Privacy Calculus of Terminally Ill Patients 
 
3.1 Related Work 
 
Information privacy has triggered a significant stream of interdisciplinary research 
(Smith et al., 2011). Due to the sensitive nature of relationships it has been a long-
recognized issue in healthcare. Health information privacy research that addresses 
the patient’s perspective has mainly considered concerns (Rindfleisch, 1997), risk 
perceptions, and information sensitivity which were found to influence the adoption 
of electronic health records (EHR) among others (Angst and Agarwal, 2009). The 
privacy calculus was introduced to social sciences by Laufer and Wolfe (1977). 
Following elaborations by Culnan and Armstrong (1999) it was refined and extended 
in order to explain how online users weigh privacy related risks against benefits, and 
became a prominent topic in IS research (Dinev and Hart, 2006). The examination 
of trade-offs has also been applied to health-related decisions (Dinev et al., 2016). 
Health information is perceived as having the highest risk profile compared to other 
personal data, when sharing decisions are considered (Milne et al., 2017). Next to 
information sensitivity, health information privacy concerns that address the use, 
collection, and access to information play a major role (Kenny and Connolly, 2016). 
To mitigate the effects of risk as a major inhibitor, control and trust are discussed. 
Perceived benefits and promises that are tied to the information sharing can 
compensate the perceived risks. Convenience, internet experience or personal 
factors (like emotions) were proposed to influence the calculus and attitudes of 
patients (Anderson and Agarwal, 2011; Dinev et al., 2015). We use the lens of the 
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privacy calculus to develop a better understanding of privacy trade-offs in 
interorganizational relationships from the perspective of the data subject. 
 
3.2 Patient’s Privacy Trade-Off  
 
Following we take the perspective of the ALS patient to examine and sketch out the 
relevant considerations in consent situations regarding APST. Perceived risks and 
benefits depend on the purpose of information usage. Thus, we distinguish between 
the main purposes or information products, as elaborated in the information 
lifecycle, to model the trade-offs that arise. In Table 1, type (1-10) and purpose of 
information (A-E), are tied to promises that a consent would yield, followed by 
potential risks. We model the perceptions based on publicly available information 
from APST, most is inferred from the data protection declaration (APST, 2020). 
 
APST makes potential benefits (promises) related to different information purposes 
tangible for the patient. Also, secondary benefits like hopes for improvement for 
future patients, that do not directly relate to the individual patient, are likely to play 
a role. The table suggests that benefits can be tied to type of information and 
purpose, while this is not obvious for risks. Privacy valuations are sensitive to 
contextual and non-normative factors (Acquisti et al., 2013). The special context of 
ALS calls for distinct considerations: As ALS is a rare disease, additional information 
for research (D, E) is even more valuable. This however also gives rise to additional 
risks: with a small sample, the risk of deanonymization is higher. Patients with special 
and immediate care needs tend to be more interested in necessary care transactions 
than in concerns about their privacy (Lafky and Horan, 2011). This is presumably 
the case for ALS patients as the disease manifests quickly. The risk of leaking 
information to employers or others becomes irrelevant as soon as the disease 
becomes manifest and insurance providers are inevitably informed once they need 
to approve aid. Patients emotional responses might also play a role as it was indicated 
that altruistic perceptions can outweigh risks (Spencer et al., 2016). 
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Table 1: Privacy calculi of APST patients 
 
Patient 
Information 
 
Purpose of 
information 
for APST 
Patients' Potential Benefits Patients' Privacy Concerns and 
Risks Tangible  Secondary  
1 Contact 
information,  
2 physician, 
care 
providers  
3 insurance 
information,   
4 social 
profile,   
5 health 
record,  
6 care and 
aid 
information,  
A Care 
management 
Free usage of 
platform,  
care provision and 
case management 
Reduced 
complexity for 
relatives 
a) Leakage, 
 
 
b) concern 
about 
inappropriate 
use,   
c) uncertainty 
about future 
use,  
d) uncertainty 
about 
information 
use and 
protection by 
platform 
partners 
e) possibilitiy of 
de- and re-
contextualizat
ion  
 
 
f) deanonymizat
ion,  
(dependent 
on statistical 
parameters of 
the  patient 
sample),  
 
 
g) risk 
perception of 
IT 
infrastructure 
(cloud 
services, 
hosting),  
B Improving 
care, process 
efficiency 
Better and faster 
care, improved 
insurance 
management 
Benefits of 
collective 
information 
sharing, funding 
for the platform  
anonymized  
7 survey 
responses,  
8 feedback 
about 
assistive 
device or 
care,  
9 care 
studies  
10 medical 
trials/ 
studies 
11 patient 
specific 
information  
C Feedback/ 
evidence-
based care 
and aid 
assessment 
and 
improvement 
Care providers can 
take feedback into 
account, overview 
over rating on 
website,  
Improved care and 
aid technology 
over time and for 
future patients, 
platform funding 
D Care 
research 
Advanced body of 
knowledge that can 
improve individual 
condition  
better care for 
future patients, 
public health 
improvement  
E Medical 
research  
individualized 
treatment (medicine, 
assistive devices)  
medical progress, 
solidarity and 
altruistic behavior 
as motivator 
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Another boundary condition to consider is trust: while APST aims to create a 
trustworthy environment, the complexity of the relationships orchestrated by the 
paltform can lead to misspecifications of trust (Möhlmann and Jarvenpaa, 2019). By 
drawing on relevant literature as well as the parameters of the case, we conjecture 
that terminally ill patients perceive higher benefits from sharing information. 
 
4 Towards an Informed Consent Calculus 
 
4.1 The Consent Dilemma  
 
Terminally ill patients depend on efficient and effective orchestration of healthcare. 
In order to receive care, information exchange with doctors and caregivers is 
inevitable. In situations of advanced care needs, however, the patient is typically 
under enormous emotional strain, left with no time nor meaningful decision rights. 
This stands in stark contrast to the assumptions of economic rationality underlying 
the privacy calculus, as patients will most likely not be able to actually fully assess 
risks and benefits. Promises or benefits are most often tangible, while risks are 
delayed and hard to grasp (Acquisti et al., 2015). APST has addressed both, legal 
requirements and the aim to provide transparency to patients, with an extensive 
privacy policy, which needs to be signed by all stakeholder (APST, 2020). However, 
research has shown that privacy policies are often neither understood nor read, 
instead they may increase information asymmetries. Therefore, users’ need to 
consent to conditions they are not able to comprehend creates a consent dilemma 
(Solove, 2012). It thus seems crucial to effectively empower patients in the context 
of a healthcare MSP, so that they understand the implications of their options as 
prerequisite for an informed and meaningful privacy calculus. 
 
4.2 A Stepwise Consent Model 
 
By proposing an exemplary stepwise, and dynamic option for consent we aim to 
illustrate how patients can be empowered to apply an informed mental calculus in 
the context of APST. Dynamic consent has been discussed in medical research for 
means of ethically gathering data for clinical trials (Spencer et al., 2016). Through 
legal advancements, dynamic consent has found its way into cookie consent 
management. We apply this approach to examine how a consent situation can be 
created that integrates the calculus and enables the patient to make an educated 
30 33
RD BLED ECONFERENCE 
ENABLING TECHNOLOGY FOR A SUSTAINABLE SOCIETY 
 
 
decision. In Table 2, we depict a possibility to manage information provision consent 
for APST in a similar fashion. We translate the findings from Table 1 and Figure 1 
in order to establish a consent option, that allows to differentiate between type of 
information and different purposes. We have developed one of the hypothetical 
consent options to share aid and medical data for information types 6, 9 and 10. 
 
Table 2: Illustration of Consent Options 
 
Your 
Information  
Your consent options 
collection 
and use 
of trans-
actional 
infor-
mation 
sharing 
of trans-
actional 
infor-
mation  
analysis 
of 
personal 
infor-
mation 
analysis 
of anony-
mized 
infor-
mation 
sharing of 
anonymized 
information 
with care 
research 
partners 
sharing of 
anonymize
d 
informatio
n with 
medical 
research 
partners 
6 care & aid 
information  x x  x x  
9 care 
studies x x  x   
10 medical 
trials  x x     
 
 
 
 
 
We draw on psychological empowerment to inform this option further. 
Psychological empowerment is based on the concepts of autonomy, self-efficacy, 
meaning and impact (Spreitzer, 1995), which are reflected in patient empowerment 
(Bravo et al., 2015, McAllister et al., 2012). The options to decide for which purpose 
and in which form patient information is used, would enable patients to make 
informed and differentiated choices about sharing information. A consent option 
like the one depicted would illustrate the data driven logic of the platform. With a 
comprehensive overview, patients are presumably more capable to assess the impact 
of information sharing. We could better inform patients’ privacy calculus by 
providing the information necessary to make a good judgement of personal risks 
Show information: 
Information about you, your care and aid prescriptions, usages, provider 
and physician information is neccessary to perform a transaction. For a 
transaction, we only share the minimum of relevant information needed. 
You can choose to provide this data in personalized or anonymized form 
for further analysis which helps to improve care efficiency, or provide it 
to relevant research efforts to advance care and medical research 
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and benefits. We try to address uncertainty about future use by providing an 
overview over a range of possible purposes. In this way, we make the information 
lifecycle transparent for the patient. Being provided with further details on the 
consent decision, patients would not only have more control and autonomy in their 
privacy decision making but also understand the impact of their choice which enable 
them to attribute meaning to their consent. As privacy preferences are also not stable 
but evolving, it would be useful to apply this consent form dynamically. With the 
options to make convenient and economic choices we thus aim at patients’ 
psychological empowerment.  
 
5 Discussion, Limitations and Outlook 
 
In the consent context of the case, patients act as active information contributors. 
By providing stepwise and dynamic consent, the patients’ ability to make informed 
decisions is extended. She is now able to choose if, how, and to whom power over 
personal information is transferred. Acting in the patients’ interest, APST thus takes 
on the role as an information trustee. By taking into account individual preferences, 
information provision can therefore be considered an exercise of sovereignty 
(Hummel et al., 2019). Still it needs to be critically assessed, if privacy in a data driven 
business model can truly be balanced in this way. It is conceivable, that reactance 
behavior is triggered and patients, as a matter of principle, have higher cautions for 
privacy and choose not to share information at all. Patients potentially react the same 
way as consumer who scrolls through software update notifications, leading to 
higher information asymmetries and a privacy apathy instead of information 
sovereignty (Hargittai and Marwick, 2016). In turn we argue that the problem of 
patient information overload can be mitgiated by structuring the decisions and 
presenting them in a way that faciltiates information consent, thus making it a design 
issue. A clear limitation is that we merely provide an exploration based on the 
theoretical as well as the case background and can not empirically validate 
perceptions and consent options. The rich theoretical background and the specific 
case insights, however, pave the way for this empirical examination of patients’ 
privacy calculus towards a multi-level use of information on a healthcare platform. 
Further examination is needed to investigate the differences in perceptions and 
valuations, to see, how they relate to the different usages of information on the 
platform. In this way, the options that we modeled in chapter four need to be refined 
and empirically validated. This paper provides a hypothetical form of enhanced 
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consent and further research needs to show how this leads to an increase in 
perceived empowerment. A first step would be to explore patients’ privacy 
perceptions under the calculus framework. Modelling these valuations into the 
consent options, psychological trade-offs that are considered between the different 
options could be assessed. To do so, we propose a conjoint analysis. Thus, we will 
also be able to examine the relative importance of different bundles of options to 
truly understand what terminally ill patients perceive as empowering. 
6 Conclusion   
 
We have shed light on the dynamics of a healthcare MSP, which strives on various 
categories of patient information (see table 1) as main resource. Adapting the 
information lifecycle we show how the platform is drawing on a logic of 
accumulation, feedback based-learning and cautious monetization typical for 
business models in the data economy, yet with the explicit goal to improve patient 
care, care research, and medical research and thus create value for patients. 
 
Information intensive practices incur considerable privacy concerns. We provide 
insights in the distinct perspective of terminally ill patients’ privacy perceptions and 
decision making. This understanding opens up possibilities to enhance a patient-
centered design in the light of a severe neurological disease. We propose a stepwise 
consent form to inform meaningful privacy options and to empower patients that 
interact with the healthcare platform. This provides an avenue for further empirical 
examination of patient empowerment that balances platform innovation, care, and 
medical research with information privacy. In this way, our research further 
contributes to the advancements of responsible and sustainable healthcare 
innovation and research practices.  
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